Cetuximab

BOSTON, July 28, 2026 Verastem Oncology announced that the first patient has been dosed in the TARGET-D 203 Phase...

LYON & CAEN, France, June 22, 2026 Lys Therapeutics has announced a major financing milestone, surpassing €25 million in...

AUSTIN, Texas, June 22, 2026 Genprex, Inc. has announced a significant intellectual property milestone after receiving a Notice of...

CASTRES, France, June 22, 2026 Laboratoires Pierre Fabre has received a major regulatory milestone with the European Commission approval...

BOSTON, June 16, 2026 Verastem Oncology announced that the first patient has been dosed in the TARGET-D 201 Phase...

Castres, France, May 22, 2026 Pierre Fabre Laboratories has announced that the Committee for Medicinal Products for Human Use...